Advanced Glycated apoA-IV Loses Its Ability to Prevent the LPS-Induced Reduction in Cholesterol Efflux-Related Gene Expression in Macrophages

• Hauptverfasser: Ligia Shimabukuro Okuda (Verfasst von), Rodrigo Tallada Iborra (Verfasst von), Paula Ramos Pinto (Verfasst von), Ubiratan Fabres Machado (Verfasst von), Maria Lucia Corrêa-Giannella (Verfasst von), Russell Pickford (Verfasst von), Tom Woods (Verfasst von), Margaret Anne Brimble (Verfasst von), Kerry-Anne Rye (Verfasst von), Marisa Passarelli (Verfasst von)
• Format: Buch
• Veröffentlicht: Hindawi Limited, 2020-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

We addressed how advanced glycation (AGE) affects the ability of apoA-IV to impair inflammation and restore the expression of genes involved in cholesterol efflux in lipopolysaccharide- (LPS-) treated macrophages. Recombinant human apoA-IV was nonenzymatically glycated by incubation with glycolaldeh...